SCHEDULE: FMR LLC and Abigail Johnson Disclose 8.6% Stake in Veracyte
Beneficial Ownership Disclosure
FMR LLC and its affiliates, along with Abigail P. Johnson, have filed an amended Schedule 13G disclosing a beneficial ownership of 8.6% in Veracyte Inc.'s common stock.
Summary
- FMR LLC and Abigail P. Johnson, through various entities, beneficially own 6,735,697.22 shares of Veracyte Inc. common stock.
- This aggregate amount represents 8.6% of Veracyte Inc.'s outstanding common stock.
- FMR LLC holds sole voting power over 6,730,720.00 shares and sole dispositive power over 6,735,697.22 shares.
- Abigail P. Johnson, as a control person of FMR LLC, is deemed to beneficially own the same 6,735,697.22 shares with sole dispositive power.
- The filing is an Amendment No. 2 to a Schedule 13G, indicating a previous disclosure of beneficial ownership.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Veracyte Inc.
Sentiment
Score: 5
Explanation: This is a routine regulatory disclosure of beneficial ownership, which is factual and does not inherently carry positive or negative sentiment regarding the company's operational performance or future prospects.
Positives
- NA
Negatives
- NA
Risks
- NA
Future Outlook
NA
Industry Context
This filing reflects a significant institutional ownership stake in Veracyte Inc., a company operating in the diagnostics or biotechnology sector. Such disclosures are routine for large asset managers like FMR LLC, indicating their continued investment in the company without necessarily implying a change in strategic direction for the issuer or the broader industry.
Comparison to Industry Standards
- NA
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's stake, which can influence market perception and liquidity.
Key Dates
| Date | Description |
|---|---|
| January 3, 2023 | Effective date of Power of Attorney for FMR LLC and its direct and indirect subsidiaries. |
| January 26, 2023 | Effective date of Power of Attorney for Abigail P. Johnson. |
| September 30, 2025 | Date of event which requires filing of this statement (reporting period end date). |
| November 4, 2025 | Date of signing the Schedule 13G and agreement for joint filing. |
Keywords
Veracyte Inc., FMR LLC, Abigail P. Johnson, Beneficial Ownership, Schedule 13G, Common Stock, Institutional Ownership, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.